Cargando…
An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice
Alzheimer's disease (AD) is the most common neurodegenerative disease. Imbalance between the production and clearance of amyloid β (Aβ) peptides is considered to be the primary mechanism of AD pathogenesis. This amyloid hypothesis is supported by the recent success of the human anti‐amyloid ant...
Autores principales: | Cheng, Yu‐Sung, Chen, Zih‐ten, Liao, Tai‐Yan, Lin, Chen, Shen, Howard C‐H, Wang, Ya‐Han, Chang, Chi‐Wei, Liu, Ren‐Shyan, Chen, Rita P‐Y, Tu, Pang‐hsien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412883/ https://www.ncbi.nlm.nih.gov/pubmed/28356312 http://dx.doi.org/10.15252/emmm.201606666 |
Ejemplares similares
-
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
por: Tramutola, Antonella, et al.
Publicado: (2018) -
Intranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice
por: Wang, Zigao, et al.
Publicado: (2017) -
Intranasal GHK peptide enhances resilience to cognitive decline in aging mice
por: Tucker, Matthew, et al.
Publicado: (2023) -
Chronic Intranasal Treatment with an Anti-Aβ(30-42) scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
por: Cattepoel, Susann, et al.
Publicado: (2011) -
Polyhydroxycurcuminoids but not curcumin upregulate neprilysin and can be applied to the prevention of Alzheimer’s disease
por: Chen, Po-Ting, et al.
Publicado: (2016)